← FDA DRUG APPROVALS

FDA ANDA · ANDA077167

DIDANOSINE

Sponsor: BARR

APPLICATION
ANDA077167
TYPE
ANDA
ORIGINAL APPROVAL
2004-12-03
LATEST ACTION
2012-02-10
ROUTE
ORAL
DOSAGE FORM
CAPSULE, DELAYED REL PELLETS
MARKETING STATUS
Discontinued

Products

DIDANOSINEDiscontinued
DIDANOSINE 250MG · CAPSULE, DELAYED REL PELLETS · ORAL
DIDANOSINEDiscontinued
DIDANOSINE 400MG · CAPSULE, DELAYED REL PELLETS · ORAL
DIDANOSINEDiscontinued
DIDANOSINE 200MG · CAPSULE, DELAYED REL PELLETS · ORAL

Approval history

2012-02-10Labeling · Supplement 7AP
2010-03-22Labeling · Supplement 5AP
2010-01-29Labeling · Supplement 4AP
2004-12-03OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →